Business News: Arcutis Biotherapeutics, Inc., Kowa Pharmaceuticals Cut Ties on US Marketing Partnership

Arcutis Biotherapeutics, Inc. and Kowa Pharmaceuticals America are ending their promotion agreement, which covered sales and promotion of roflumilast (Zoryve) by Kowa to primary care physicians and pediatricians in the United States.